Sign In
Buy APM
$0.83
-0.0298 (-3.47%)
At Close: Jun 23, 2026
NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, June 22, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company d
Statement in Response to Silver Elephant's News Release Dated June 17, 2026
05:29pm, Thursday, 18'th Jun 2026
Toronto, Ontario--(Newsfile Corp. - June 18, 2026) - Andean Precious Metals Corp. (TSX: APM) (OTCQX: ANPMF) ("Andean" or the "Company") is aware of the news release issued by Silver Elephant Mining
Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences
08:00am, Wednesday, 10'th Jun 2026
NEW YORK, NY, June 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company dedicated to addressing unmet medical needs, today annou
Andean Precious Metals Corp. (APM:CA) Q1 2026 Earnings Call Transcript
01:10pm, Wednesday, 13'th May 2026
Andean Precious Metals Corp. (APM:CA) Q1 2026 Earnings Call Transcript
Head-To-Head Survey: Aptorum Group (NASDAQ:APM) versus Catalyst Pharmaceuticals (NASDAQ:CPRX)
01:11am, Thursday, 16'th Apr 2026
Aptorum Group (NASDAQ: APM - Get Free Report) and Catalyst Pharmaceuticals (NASDAQ: CPRX - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two b
Aptorum Group Limited (NASDAQ:APM) Short Interest Up 41.4% in March
01:29am, Tuesday, 14'th Apr 2026
Aptorum Group Limited (NASDAQ: APM - Get Free Report) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totaling 12,292 shares, a growth of 41.
Prelude Therapeutics (NASDAQ:PRLD) vs. Aptorum Group (NASDAQ:APM) Critical Review
01:40am, Tuesday, 07'th Apr 2026
Aptorum Group (NASDAQ: APM - Get Free Report) and Prelude Therapeutics (NASDAQ: PRLD - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the t
Andean Precious Metals Q4 Earnings Call Highlights
01:32am, Friday, 27'th Mar 2026
Andean Precious Metals (TSE: APM) used its fourth-quarter and year-end earnings call to highlight what management described as a "step change" in 2025 results, driven by record financial performance,
Andean Precious Metals Corp. (APM:CA) Q4 2025 Earnings Call Transcript
10:56am, Wednesday, 25'th Mar 2026
Andean Precious Metals Corp. (APM:CA) Q4 2025 Earnings Call Transcript
Aptorum Group Limited (NASDAQ:APM) Sees Significant Growth in Short Interest
03:16am, Wednesday, 18'th Mar 2026
Aptorum Group Limited (NASDAQ: APM - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling 11,553 s
NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, March 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
04:30pm, Friday, 06'th Mar 2026
Hong Kong, March 06, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM), a leading Biotechnology company, today announced that it has received a notification from the Nasdaq Stock Market LLC
NEW YORK, NY; NEW HAVEN, CT; PRINCETON, NJ, and TAIPEI, TAIWAN, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmace
Short Interest in Aptorum Group Limited (NASDAQ:APM) Drops By 75.1%
03:52am, Wednesday, 14'th Jan 2026
Aptorum Group Limited (NASDAQ: APM - Get Free Report) saw a large decline in short interest during the month of December. As of December 31st, there was short interest totaling 2,681 shares, a decline
NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and
